Objective: The transient outward current ( ITo) plays an important role in early repolarization and overall time course of the cardiac action potential. At least two K' channel a-subunits cloned from cardiac tissue (Kvl.4 and Kv4.2) encode rapidly inactivating channels. The goal of this study was to determine functional and pharmacological properties of Kv4.2 expressed in mammalian cells, especially those that would differentiate between both isoforms in comparison to native I,,. Methods: Both Kv4.2 and Kv 1.4 isoforms were stably expressed in mouse L-cell lines, and expressed currents were studied using whole-cell voltage clamp techniques. Results: The expressed Kv4.2 currents displayed fast inactivation with a half-inactivation potential of -41 mV. Recovery from inactivation was rapid (km" = 160 ms at -90 mV) and strongly voltage-dependent. Flecainide (10 PM) had minimal effects on Kv 1.4 currents, but reduced Kv4.2 peak current by 53% and increased the apparent rate of inactivation consistent with open channel block. Quinidine (IO-20 FM) reduced the peak current and accelerated the apparent rate of inactivation in both isoforms. The Kv4.2 current displayed use-dependent unblock in the presence of 4-AP. Conclusions: The functional properties of Kv4.2, especially the flecainide sensitivity, resemble those of ITo in rat (and human) myocytes better than those of Kv1.4. These results provide the necessary functional support for the hypothesis that Kv4.2 is a major isoform contributing to cardiac I,,, consistent with independent biochemical and molecular evidence that indicates that Kv4.2 is readily detected in rat myocytes.
Introduction
The transient outward current (ITo) plays an important role in shaping the early phase of the cardiac action potential (early repolarization and notch). As such, ITo may influence the balance of the currents during the plateau phase and thus modulate the duration of the action potential and refractoriness of myocardial tissue [l] . The Kvl.4 channel, cloned from rat and human cardiac cDNA libraries, has been suggested as the molecular basis for this current 12-51. This clone indeed encodes an inactivating Kt channel [2, 3, 5] , but the voltage dependence of activation, inactivation and especially the time course of recovery from inactivation display significant differences compared with the voltage-gated transient outward current in human and rat cardiac myocytes (Table 1) . These discrepancies are attenuated, but only in part, by heterotetramer formation with other Kvl family a-subunits [6] . In addition, they are not normalized by coexpression with Kvfi subunits: both Kv p 1.1 and Kv p 1.2 subunits further slow recovery from inactivation in Kvl.4 [7, 8] . Despite the presence of Kv 1.4 mRNA in rat and human heart, [2, 9] more detailed molecular studies have failed to detect Kv 1.4 mRNA or protein in rat cardiac myocytes [lo,1 l] . Similar studies have indicated that another inactivating K+ channel from the Shal family (Kv4.2), cloned from rat heart [4, 12, 13] , is abundantly expressed in rat myocytes [ 111. The density of ITo increases from endo-to epicardial layers in rat, canine and human ventricle . The distribution of Kv4.2 mRNA displays the same regional S. W. Yeola, D.J. Snyders / Cardio~mcular Research 33 (19971 540-547 heterogeneity in rat ventricle, while no such gradient was observed for Kv 1. 4 [ 101. However, a recent report documented the presence of Kvl.4 and Kv4.2 in ferret myocytes [17] . Therefore, functional properties of each isoform need to be considered in conjunction with the molecular evidence to assess the putative contribution of cloned subunits to molecular architecture of the native current.
Our goal was to test whether the functional and pharmacological properties of Kv4.2 would correspond more closely to those of the native transient outward current, which is efficiently blocked by quinidine [18-201 and flecainide [ 18, 191 . Several cloned Kv 1 .x isoforms (Kv 1.1, 1.2, 1.3, 1.5) display limited sensitivity to flecainide (EC,, 53-217 pmol/l) [2 11. This suggested that Kv1.4 might not be very sensitive to flecainide, and that flecainide could be used as a tool to rule out some candidate subunits. We now report on the properties of Kv4.2, expressed in mammalian cells and studied under experimental conditions similar to those used to study myocytes. In the present study we specifically tried to identify functional and/or pharmacological properties which would differentiate between Kv 1.4 and Kv4.2, as compared to the native transient outward current.
Methods

Tramfection and cell culture
The transfection procedure to establish the stable cell lines expressing Kv 1.4 and Kv4.2 [4] has been described in detail elsewhere [22, 23] . In both cases, cell lines transfected with the same vector but lacking the ion channel cDNA were prepared in parallel to serve as negative controls (sham-transfected cell lines). Cell culture and cell preparation for experimental use were as reported previously 122,231. Three independent transfections with the rat Kv4.2 isoform yielded positive foci each, from which a total of 8 clonal cell lines were analyzed. Expression levels were low to modest (< 1 nA/cell) in each, with similar functional properties.
Electrical recording
Recordings were made with an Axopatch-1 or Axopatch-200A patch clamp amplifier (Axon Instruments, Foster City, CA) using the whole-cell configuration of the patch clamp technique. Currents were recorded at room temperature (23"(Z), and were sampled at 2-10 kHz after anti-alias filtering at l-5 kHz. Data acquisition and command potentials were controlled by a custom made programmable stimulator. Micropipettes were pulled from starbore borosilicate glass (Radnoti Glass Co., Monrovia, CA) and were heat-polished. To ensure voltage clamp quality, electrode resistance was kept below 3 MR; the average resistance was 1.8 f 0.1 MR (mean * s.e., n = 23). Junction potentials were zeroed with the electrode in the standard bath solution. Gigaohm seal formation was achieved by suction (9.1 + 0.7 Gfi, n = 21). After establishing the whole-cell configuration, the capacitive transients elicited by symmetrical 10 mV voltage clamp steps from -80 mV were recorded at 50 kHz for calculation of cell capacitance, access resistance and input impedance [22] . The average access resistance was 2.9 & 0.2 MR (n = 231, and after analog compensation the residual access resistance was 1.1 + 0.1 Ma. With an average current of 259 + 29 pA (for Kv4.2) at +60 mV and 1.8 + 0.4 nA (for Kv 1.4), voltage errors were less than 3 mV based on the calculated residual access resistance. 
Pulse protocols and data analysis
The holding potential was -80 mV for Kv4.2 and -100 or -120 mV for Kvl.4 unless indicated otherwise. Effects of drug infusion or removal were monitored with test pulses to + 50 mV, applied every 20 s until steady-state was obtained. The cycle time for other protocols was at least 15 s for Kv4.2, while the slow recovery from inactivation for Kvl.4 required cycle times of 30 s or longer. Steady-state current-voltage relationships were obtained by averaging the current over a small window (2-5 ms). Peak current levels were obtained from the best secondorder polynomial fit to the data points in a lo-20 ms window moving around the peak. Between -120 and -50 mV only passive linear leak was observed; leastsquare fits to these data were used for passive leak correction. L-cells have a virtually linear input impedance of 2-5 GLR up to + 30 mV 1221, but at more positive voltages the time-independent background current in sham-transfected cells is somewhat higher (25-45 pA at + 50 mV>. Because of the small Kv4.2 currents in many cells, this non-linearity was taken into account in the leak correction. Raw tracings shown in this paper were corrected for leak and capacitive transients and digitally filtered at 1 kHz in the frequency domain after Fourier transformation.
The time course of inactivation, recovery from inactiva- 
where k represents the slope factor, E the imposed voltage and E, the voltage at which 50% of the channels are inactivated. The curve fitting procedure used a non-linear least squares (Gauss-Newton) algorithm; results were displayed in linear and semilogarithmic format together with a plot of the residual deviations of the data from the fitted curve (difference plot). Goodness of the fit and required number of exponential components were judged by comparing x2 values statistically (F-test) and by inspection for systematic non-random trends in the difference plot. The effects of quinidine and flecainide were determined both from the reduction of peak outward current and the reduction of the time-integral of the open channel current.
Results are expressed as mean * s.e.m. Analysis of variance with appropriate post hoc comparisons was used to compare the differences in mean values; P < 0.05 was considered significant.
Results
Functional properties of Kv4.2
L-cells transfected with the Kv4.2-cDNA-containing vector displayed voltage-gated currents which inactivated rapidly (transient outward phenotype) as is illustrated in Fig. 1A . The threshold for activation was around -25 mV. The expressed currents displayed rapid activation with a time to peak of 9.5 t-0.3 ms ( IZ = 11) at + 50 mV. The peak outward current at + 60 mV ranged from 55 to 600 PA/cell with an average peak current of 259 + 29 pA corresponding to 16.2 + 1.6 pA/pF (n = 23). The average current-voltage relationship (n = 23) for the peak current normalized to cell capacitance is illustrated in Fig. 1B . Neither untransfected L-cells nor sham-transfected cells displayed voltage-gated ionic currents, as has been reported previously [22] .
The degree of inactivation induced during a 400 ms conditioning step to various potentials was assessed from the normalized suppression of peak current during a fixed test depolarization to + 50 mV. An example of the voltage dependence of inactivation determined using this prepulse protocol is shown in Fig. 1C . The Kv4.2 current was maximally available up to -60 mV, but almost fully inactivated by a prepulse to -20 mV. A Boltzmann fit to the voltage dependence of inactivation yielded an average midpoint of -41 f 1 mV (n = 22) and slope factor -6.4 f 0.2 mV (n = 22).
We found that a monoexponential function provided a good fit to the time course of fast inactivation during depolarizing steps. The inset in Fig. 2A shows an example of such a fit with a time constant of 30 ms for a tracing at + 50 mV. The average value at this voltage was 31 .l + 1.4 ms (n = 20). The time constant for inactivation displayed little voltage dependence positive to +20 mV, but was slower near the activation threshold. This is illustrated both by the raw tracings in Fig. 1A and by the average time constants shown in Fig. 2A summarizing results from 20 experiments.
A characteristic of the transient outward current in rat and human cardiac myocytes is the fast recovery from inactivation (see Table 1 Membrane Potential (mV) 160f 8 ms (n= 12>, compared to 258 * 13 ms at -80 mV (n = 15) and 123 k 7 at -100 mV (n = 5). To test for accumulation of inactivation we used pulse trains of 250 ms depolarizing steps to +50 mV from a holding potential of -80 mV at frequencies of 1, 0.5 and 0.2 Hz. The peak currents were normalized to the size of the first current in the train. Fig. 2C shows the average results from 9 experiments at each stimulus frequency. The expressed Kv4.2 current showed a small depression during 1 Hz trains (10 k 3%, P < 0.05), but no significant suppression was observed at 0.5 or 0.2 Hz. In contrast, significant use -dependent suppression has been reported for Kv 1.4 [6] . This was further confirmed in a small number of experiments included in Fig. 2C These functional data suggested that Kv4.2 may more closely correspond to the transient outward current in rat myocytes, but such functional resemblance may be fortuitous. Therefore, we next sought to determine pharmacological properties that would better discriminate between these subunits. The transient outward current in rat and human myocytes is more than 50% suppressed with 10 p,M flecainide [ 18,191. To test whether flecainide could be used as a pharmacological discriminator, we compared its effects on Kv4.2 and Kv1.4. Fig. 3A shows that 10 PM flecainide markedly suppressed the peak outward current of Kv4.2, and induced a subsequent acceleration of apparent inactivation. The reduction of peak current at + 50 mV was 53 $-2% (n = 4). Because the kinetics changed, the reduction of the peak current may not adequately reflect the degree of block. Therefore, we also measured the current-time integral for the open channel current, and found 72 & 4% (n = 4) suppression with flecainide. The rate of apparent inactivation increased approximately twofold with a time constant of 15 f 3 ms (n = 4, P < 0.01). This acceleration was observed at all voltages between 20 and 60 mV ( Fig. 2A) . In contrast, the same concentration of flecainide had minimal effects on Kvl.4 (Fig. 3B) . In 5 experiments the peak outward current was reduced by only 11 + 2% and the time-integral was reduced by 6 i 7%. The time course of inactivation of Kv 1.4 is better described by a double exponential function [5] , but the dominant fraction of decline (70 + 4%) occurred with a time constant of 35 & 2 ms (n = 4). No significant effect of flecainide was observed (7 = 33 k 3 ms, IZ = 4, P = NS). The differences in the effects of IO p,M flecainide on reduction of peak current and time-integral were highly significant between Kv 1.4 and Kv4.2 (P < 0.01)
The native transient outward current in various species is sensitive to quinidine (see Section l), but Kv1.4 has been reported to be relatively insensitive to quinidine (EC,, = 700 p,M) when expressed in Xenopus oocytes [24] . We determined the sensitivity to quinidine of both isoforms expressed in these mammalian cells under experimental conditions that more closely resemble those used in myocyte studies. Typical examples are shown in Fig.  3(C,D) . tn contrast to the results reported in oocytes [24] , 20 pM quinidine suppressed Kvl.4 markedly. The suppression of peak current by 47 f 5% (n = 4) was followed by an accelerated 'inactivation' with a fast exponential component of 6 + 1 ms (n = 4). Similarly, at + 50 mV, peak Kv4. The transient outward current in various myocytes is sensitive to 4-AP. Fig. 4A shows that 2 mM 4-AP also reduced the expressed Kv4.2 current evoked by depolarization to + 50 mV from a holding potential of -80 mV. At this voltage the average reduction of the peak outward current was 57 rt 4% (n = 5). However, the suppression of current and the modification of the time course was complex and depended on the interpulse interval. This aspect was further investigated using pulse trains at 1 Hz after a 60 s resting period at -80 mV. During the first depolar-1 o Pulse Number 100 ms 100 ms ization to f50 mV, both activation and inactivation were slowed compared to the subsequent tracings that all superimposed. This resulted in the crossover phenomenon illustrated in Fig. 4B . As a result, reduction of peak Kv4.2 current by 2 mM 4-AP was 66 & 5% (n = 5) during the first pulse, but only 44 + 6% in steady-state conditions during 1 Hz trains. We were unable to demonstrate such effects for Kvl.4 due to its intrinsic use-dependent accumulation of inactivation during similar pulse trains (see Fig. 2C ).
quinidine in rat ventricular myocytes [ 181, similar to the 71% value for Kv4.2 observed in the present study. We did observe significant block of Kv 1.4 channels expressed in L-cells at low quinidine concentrations (20 p,M), which implies that quinidine cannot be used as a pharmacologic argument against Kv 1.4 as a possible contributor to I,,.
Discussion
Our findings demonstrate significant functional and pharmacological differences between expressed Kv4.2 and Kv1.4 currents. While both isoforms inactivated rapidly with comparable rates, Kv4.2 recovered from inactivation 20-40-fold faster than Kv1.4. As a result Kv4.2 did not display marked use-dependent accumulation of inactivation. Both isoforms were sensitive to quinidine and 4-AP, but only Kv4.2 was significantly affected by 10 pM flecainide.
Pharmacological correspondence between Ku4.2 and natirle ITO
The results obtained with flecainide provide strong discriminatory evidence favoring Kv4.2 over Kvl.4 as an important candidate subunit to form the molecular basis of the transient outward current in rat (and potentially human) cardiac myocytes. The limited effect of 10 p,M flecainide on Kv 1.4 (1 1% block) would correspond to an EC 50 of 8 1 FM, which is in range of the EC,,'s (53-201 p,M) reported for other Kv1.x isoforms [21] . In contrast, the reduction of peak Kv4.2 current (53%) is in reasonable agreement with the 41% suppression of peak I,, in human atria1 myocytes [19] . The 72% reduction of the current-time integral is in quantitative agreement with the 73% reduction of integrated ITo observed by Slawsky and Castle in rat ventricular myocytes [18] . Assuming a bimolecular reaction, our results would be consistent with an EC,, around 3 pM in agreement with their value of 3.7 pM. The two-fold increase in the rate of apparent inactivation of Kv4.2 also compares well with the -1.5 and w 4-fold increase observed with 10 p,M flecainide in human atria1 and rat ventricular myocytes, respectively [ 18, 191 . This accelerated inactivation has been proposed to reflect open channel block [18, 19] . Thus the affinity and kinetics of the interaction of flecainide is shared between rat and human ITo and Kv4.2, but not Kv1. 4 .
In rat and human myocytes 10 FM quinidine has been
The effects of 4-AP display complex state-, time-and voltage-dependencies in many preparations, making quantitative comparisons between preparations and isoforms more difficult. Qualitatively, the sensitivity of the transient outward current to 4-AP is shared by both cloned isoforms. The 57% suppression of Kv4.2 current after a 15 s rest is consistent with the EC,, of 2 mM observed for human atrial ITo [ 191. For rat myocytes, a lower value (0.2 mM) has been reported [20] , but the same study showed detectable I,, in the presence of 10 mM 4-AP, depending on the holding potential and pulse patterns. An important qualitative signature of the interaction of 4-AP with I,, is the use-dependent unblock observed in rat [20] , ferret [26] and human cardiac myocytes [19] . This unblock occurs mostly during the first depolarization. Only Kv4.2 displayed the resulting characteristic cross-over phenomenon (Fig. 4B) . Indeed, the very slow repriming kinetics of Kv 1.4 precluded observation of this phenomenon, consistent with results obtained in oocytes [27] . A detailed study of the interaction of 4-AP with Kv4.2 was beyond the scope of the present study. Nevertheless, the results indicate that the Kv4.2 currents display important features of the interaction of 4-AP with cardiac I,,.
Functional correspondence between Kr~4.2 and IT0
A major functional difference between Kv 1.4 and Kv4.2 currents resides in the kinetics of recovery from inactivation. Kvl.4 recovers slowly (time constant of 2-8 s) 23,281, and this time constant displays little or no voltage dependence between -80 and -120 mV. As a result, the expressed current displays extensive use-dependent suppression during fast (0.2-I .O Hz) pulse trains [6] . In rat, canine and human myocytes, Zro recovers quickly from inactivation (Table 1 ) with a time constant that displays a steep voltage dependence [ 14, 29, 30] . The time constant for recovery for Kv4.2 displayed a similar voltage dependence declining from 258 to 123 ms between -80 and -100 mV. Admittedly, these values are 3-5 times slower than in rat and human myocytes, which may suggest a role for additional subunits [3 11 . Another potential explanation is the effect of divalent cations used to block calcium currents in myocyte experiments (see below). Consistent with the fast recovery, the native ITo displays little or no use-dependent inactivation during pulse trains up to 1 Hz [30, 32] , a property shared by Kv4.2 (Fig. 2C ). shown to reduce ITo peak current by 50-75% and to Kv4.2 inactivated at more positive potentials compared induce an accelerated decline of current [ 18, 19, 25] , similar to Kvl.4 (Fig. lC, Table 1 ). The value for its midpoint for to our observations for Kv4.2. The reduction of the curinactivation is generally more consistent with those obrent-time integral was approximately 75% with 10 PM tained in most cardiac preparations (Table I) , especially if [33] . Similarly, in human myocytes a value of -45 mV was found in the absence of Cd2+, compared to values between -2 1 and -34 mV in its presence [14, 30, 33] . This corresponds nicely with the 23 mV depolarizing shift (from -45 to -22 mV) of the inactivation curve for Kv4.2 induced by 300 PM Cd2+ (Fiset, Clark, Shimoni and Giles, personal communication). The depolarizing shift of voltage-dependent parameters would also be expected to increase the rate of recovery at negative potentials.
Molecular basis of I,,
Other inactivating subunits have been cloned from rat and human brain (e.g., Kv3.3 and Kv3.4) [34-361. It is unlikely that these subunits would be major contributors to rat or human ITo since no significant mRNA for either isoform was detected in rat heart [lo] . Moreover, the Kv3.x channels are highly sensitive to external TEA [34- 361 in contrast to rat and human ITo [18, 30] . A transient outward current could be due to co-assembly of Kvl .x with KvB subunits. However, the flecainide sensitivity of the native current and the relative insensitivity of Kv1.x family members to this drug makes this unlikely.
Another Shal isoform, Kv4.3, recently cloned from rat brain, is expressed in rat atria [37] . Its functional properties are similar to those of rat Kv4.2 or canine Kv4.3 [38] . Our results do not exclude the possibility that some of the differences between Kv4.2 studied here and human ITo could be due to species-specific isoform differences or co-assembly with Kv4.3 [38] .
Conclusion
In conclusion, the distinct functional and pharmacological profile of Kv4.2 and Kv 1.4 indicates that the S/r&type current corresponds more closely to the transient outward current observed in rat (and human) cardiac myocytes than does Kvl.4. Our results do not rule out association of Kv4.2 with accessory subunits. For rat myocytes, these results provide the necessary functional counterpart for the biochemical evidence supporting a role for Kv4.2 but not Kvl.4 (see Section 1). The pharmacological differences may provide clues to the molecular nature of the binding site for flecainide and other antiatrhythmic drugs, and a distinct molecular basis for ITo may enable the development of antiarrhythmic drugs that would show less crossreactivity between ITo and cardiac delayed rectifiers from the Kvl family (e.g., Kv1.2 and Kv1.5).
